About BLOODSCAN BIOTECH INC.
BloodScan Biotech is a company specializing in liquid biopsy technology that detects circulating tumor cells (CTCs) from blood samples, offering early and non-invasive cancer diagnosis. Their Labyrinth One system isolates intact CTCs for genomic and treatment-relevant insights.
CTC analysis from a single blood tubeEarly cancer detection, even before Stage 0Isolation of intact circulating tumor cells (CTCs)High-throughput, automated CTC enrichment97% genomic concordance with matched tissueNon-invasive biopsy-equivalent alternative for patients where tissue biopsy is impractical
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to BLOODSCAN BIOTECH INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.